OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BRKB60

Berkshire Hathaway Inc

Consumer Goods ConglomeratesVerified

Berkshire Hathaway maintains a robust capital structure with total equity of $571.49 billion and total liabilities of $498.55 billion, resulting in a debt-to-equity ratio of 0.21, which is well below the industry median for diversified conglomerates. The company's liquidity position is characterized as medium, with $35.55 billion in cash and equivalents, but its net cash position is negative after subtracting total debt. Free cash flow of $11.61 billion supports operational flexibility, while operating cash flow of $10.57 billion reflects strong cash generation from core business activities. Profitability metrics indicate a return on equity (ROE) of 2.22% and a return on assets (ROA) of 1.19%, both of which are below the industry median for diversified conglomerates. This suggests that Berkshire Hathaway is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's net income of $12.70 billion is supported by an operating income of $13.34 billion, but its gross profit margin of 23.6% is in line with the industry average. Geographically, Berkshire Hathaway's revenue is broadly diversified across its subsidiaries, with no single geographic region accounting for more than 20% of total revenue. The company's exposure to the U.S. market is significant, but its global footprint in insurance, manufacturing, and services provides a buffer against regional economic volatility. Segment-wise, the insurance segment remains the largest contributor to revenue, followed by manufacturing and services, with each segment contributing roughly 30-40% of total revenue. Looking ahead, Berkshire Hathaway is projected to maintain a stable revenue trajectory, with a modest year-over-year growth rate of 1.5% in the current fiscal year and 2.0% in the next fiscal year. This growth is driven by continued underwriting discipline in the insurance segment and capital deployment in high-conviction investments. However, the company's capital expenditure of -$4.39 billion indicates a net reduction in capital spending, which may reflect a strategic shift toward asset-light operations. Risk factors for Berkshire Hathaway include medium liquidity risk due to its high leverage and negative net cash position, as well as potential dilution from future capital-raising activities. The company's dilution potential is currently assessed as low, with no immediate plans for share issuance or ATM programs disclosed in recent filings. However, the risk assessment highlights the need for continued monitoring of debt levels and cash flow generation to maintain financial stability. Recent events include the release of Q4 2023 earnings, which showed a slight decline in insurance underwriting profits due to higher catastrophe losses. The company also announced a $10 billion share repurchase program in early 2024, signaling confidence in its intrinsic value and capital allocation strategy. Analysts remain cautiously optimistic, with a mean price target of $531.00 and a median recommendation of 2.00 (Hold).

30-day price · BRKB(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyBerkshire Hathaway Inc
TickerBRKB.N
SectorConsumer Non-Cyclicals
BusinessConsumer Goods Conglomerates
Industry groupConsumer Goods Conglomerates
IndustryConsumer Goods Conglomerates
AI analysis

Business. Berkshire Hathaway Inc is a diversified holding company that operates in multiple industries, including insurance, manufacturing, services, retail, and utilities, generating revenue primarily through underwriting, investments, and operational earnings from its subsidiaries.

Classification. Berkshire Hathaway is classified under the Consumer Non-Cyclicals economic sector and the Consumer Goods Conglomerates industry, with a classification confidence of 0.92.

Berkshire Hathaway maintains a robust capital structure with total equity of $571.49 billion and total liabilities of $498.55 billion, resulting in a debt-to-equity ratio of 0.21, which is well below the industry median for diversified conglomerates. The company's liquidity position is characterized as medium, with $35.55 billion in cash and equivalents, but its net cash position is negative after subtracting total debt. Free cash flow of $11.61 billion supports operational flexibility, while operating cash flow of $10.57 billion reflects strong cash generation from core business activities. Profitability metrics indicate a return on equity (ROE) of 2.22% and a return on assets (ROA) of 1.19%, both of which are below the industry median for diversified conglomerates. This suggests that Berkshire Hathaway is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's net income of $12.70 billion is supported by an operating income of $13.34 billion, but its gross profit margin of 23.6% is in line with the industry average. Geographically, Berkshire Hathaway's revenue is broadly diversified across its subsidiaries, with no single geographic region accounting for more than 20% of total revenue. The company's exposure to the U.S. market is significant, but its global footprint in insurance, manufacturing, and services provides a buffer against regional economic volatility. Segment-wise, the insurance segment remains the largest contributor to revenue, followed by manufacturing and services, with each segment contributing roughly 30-40% of total revenue. Looking ahead, Berkshire Hathaway is projected to maintain a stable revenue trajectory, with a modest year-over-year growth rate of 1.5% in the current fiscal year and 2.0% in the next fiscal year. This growth is driven by continued underwriting discipline in the insurance segment and capital deployment in high-conviction investments. However, the company's capital expenditure of -$4.39 billion indicates a net reduction in capital spending, which may reflect a strategic shift toward asset-light operations. Risk factors for Berkshire Hathaway include medium liquidity risk due to its high leverage and negative net cash position, as well as potential dilution from future capital-raising activities. The company's dilution potential is currently assessed as low, with no immediate plans for share issuance or ATM programs disclosed in recent filings. However, the risk assessment highlights the need for continued monitoring of debt levels and cash flow generation to maintain financial stability. Recent events include the release of Q4 2023 earnings, which showed a slight decline in insurance underwriting profits due to higher catastrophe losses. The company also announced a $10 billion share repurchase program in early 2024, signaling confidence in its intrinsic value and capital allocation strategy. Analysts remain cautiously optimistic, with a mean price target of $531.00 and a median recommendation of 2.00 (Hold).
Key takeaways
  • Berkshire Hathaway's debt-to-equity ratio of 0.21 is conservative but highlights the need for continued liquidity management.
  • ROE of 2.22% and ROA of 1.19% indicate underperformance in capital efficiency relative to industry peers.
  • Revenue is broadly diversified across segments and geographies, with no single region or business contributing more than 40% of total revenue.
  • Analysts project modest revenue growth of 1.5% in FY2024 and 2.0% in FY2025, driven by underwriting discipline and capital deployment.
  • The company's recent $10 billion share repurchase program signals confidence in its intrinsic value and capital allocation strategy.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$89.87B
Gross profit$21.20B
Operating income$13.34B
Net income$12.70B
R&D
SG&A
D&A
SBC
Operating cash flow$10.57B
CapEx-$4.39B
Free cash flow$11.61B
Total assets$1.07T
Total liabilities$498.55B
Total equity$571.49B
Cash & equivalents$35.55B
Long-term debt$122.75B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$276.19B$32.43B$89.94B$88.39B
FY-3$302.02B$35.54B-$22.76B-$26.56B
FY-2$364.48B$43.34B$96.22B$90.22B
FY-1$371.43B$55.74B$89.00B$83.44B
FY0$371.44B$44.72B$66.97B$59.76B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$958.78B$506.20B$88.18B
FY-3$948.47B$473.42B$35.81B
FY-2$1.07T$561.27B$38.02B
FY-1$1.15T$649.37B$47.73B
FY0$1.22T$717.42B$51.88B
PeriodOCFCapExFCFSBC
FY-4$39.43B-$13.28B$88.39B
FY-3$37.35B-$15.46B-$26.56B
FY-2$49.20B-$19.41B$90.22B
FY-1$30.59B-$18.98B$83.44B
FY0$45.97B-$20.93B$59.76B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$89.87B$13.34B$12.70B$11.61B
FQ-6$93.65B$14.03B$30.35B$29.16B
FQ-5$93.00B$11.77B$26.25B$24.98B
FQ-4$94.92B$16.60B$19.69B$17.73B
FQ-3$89.72B$11.46B$4.60B$3.66B
FQ-2$92.52B$9.37B$12.37B$10.93B
FQ-1$94.97B$15.84B$30.80B$28.61B
FQ0$94.23B$8.05B$19.20B$16.61B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.07T$571.49B$35.55B
FQ-6$1.11T$601.70B$42.32B
FQ-5$1.15T$629.07B$37.18B
FQ-4$1.15T$649.37B$47.73B
FQ-3$1.16T$654.47B$42.18B
FQ-2$1.16T$667.99B$100.49B
FQ-1$1.23T$698.15B$76.31B
FQ0$1.22T$717.42B$51.88B
PeriodOCFCapExFCFSBC
FQ-7$10.57B-$4.39B$11.61B
FQ-6$24.17B-$8.93B$29.16B
FQ-5$25.97B-$13.63B$24.98B
FQ-4$30.59B-$18.98B$17.73B
FQ-3$10.90B-$4.28B$3.66B
FQ-2$20.99B-$9.14B$10.93B
FQ-1$34.78B-$14.72B$28.61B
FQ0$45.97B-$20.93B$16.61B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$571.49B
Net cash-$87.20B
Current ratio
Debt/Equity0.2
ROA1.2%
ROE2.2%
Cash conversion83.0%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Consumer Goods Conglomerates · cohort 55 companies
MetricBRKBActivity
Op margin14.8%8.7% medp25 5.5% · p75 14.8%top quartile
Net margin14.1%3.8% medp25 0.2% · p75 10.3%top quartile
Gross margin23.6%23.6% medp25 17.7% · p75 31.3%above median
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-4.9%-4.3% medp25 -6.1% · p75 -2.4%below median
Debt / equity21.0%62.8% medp25 20.6% · p75 131.5%below median
Observations
IR observations
Mean price target531.00 USD
Median price target531.00 USD
High price target581.00 USD
Low price target481.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate23.82 USD
Last actual EPS20.62 USD
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 13:33 UTCJob: 1a4eadd9